Interferon‐α plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers

Background: The effectiveness and tolerability of combination therapy for 12 months have not been evaluated sufficiently in chronic hepatitis C relapsers to interferon. Aims: To evaluate the sustained response to interferon plus ribavirin for 12 months in chronic hepatitis C relapsers. Methods: We i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2002-02, Vol.16 (2), p.243-249
Hauptverfasser:	Moreno‐Monteagudo, J. A., Castro, A., De Pedro, A., Lorenzo, J. A., Fernández‐Bermejo, M., Lopez, S., García‐Buey, L., Borque, M. J., Pedreira, J. D., Moreno‐Otero, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alanine Transaminase - blood Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Biological and medical sciences Digestive system Drug Therapy, Combination Female gamma-Glutamyltransferase - blood Genotype Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - etiology Hepatitis C, Chronic - genetics Humans Interferon-alpha - administration & dosage Interferon-alpha - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments Recurrence Ribavirin - administration & dosage Ribavirin - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!